Table 6.6g

Immunosuppression Use for Maintenance Between Discharge

and One Year Following Transplantation, 1996 to 2005

Recipients with Pancreas Transplant Alone (PTA) Transplants

  Year of Transplant
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
Transplants 51 79 88 139 134 167 180 158 182 198
Tx with Follow-up Immunosuppression Info 30 46 63 109 96 122 142 115 136 147
Corticosteroids Any in Category 96.7% 100.0% 100.0% 100.0% 96.9% 92.6% 86.6% 56.5% 56.6% 53.7%
Steroids 96.7% 100.0% 100.0% 100.0% 96.9% 92.6% 86.6% 56.5% 56.6% 53.7%
Cyclosporine Any in Category 43.3% 23.9% 19.0% 8.3% 8.3% 5.7% 8.5% 7.0% 3.7% 2.0%
Sandimmmune 10.0% 2.2% 0.0% 0.0% 2.1% 0.0% 0.0% 0.0% 0.0% 0.7%
Neoral 33.3% 21.7% 19.0% 8.3% 5.2% 5.7% 6.3% 6.1% 3.7% 1.4%
Gengraf 0.0% 0.0% 0.0% 0.0% 1.0% 0.0% 1.4% 0.9% 0.0% 0.0%
Eon 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.7% 0.0% 0.0% 0.0%
Tacrolimus Any in Category 80.0% 80.4% 96.8% 96.3% 95.8% 98.4% 95.1% 84.3% 85.3% 98.0%
Tacrolimus 80.0% 80.4% 96.8% 96.3% 95.8% 98.4% 95.1% 84.3% 85.3% 98.0%
Antimetabolites Any in Category 93.3% 91.3% 93.7% 93.6% 81.3% 73.8% 64.1% 60.0% 58.8% 63.3%
Mycophenolate Mofetil 80.0% 78.3% 81.0% 91.7% 76.0% 70.5% 64.1% 59.1% 52.9% 55.8%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 4.1%
Azathioprine 13.3% 13.0% 12.7% 1.8% 5.2% 3.3% 0.0% 0.9% 5.9% 3.4%
Cytoxan 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
mTOR Inhibitors Any in Category 0.0% 0.0% 0.0% 17.4% 27.1% 16.4% 33.1% 24.3% 26.5% 27.2%
Sirolimus 0.0% 0.0% 0.0% 17.4% 27.1% 16.4% 33.1% 24.3% 26.5% 27.2%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%


Source: OPTN/SRTR Data as of May 1, 2007.

Percentages are calculated based on the total number of patients with any immunosuppression use between discharge and one year following transplantation.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug within the same category.